Author:
de Jonge Maja,Verweij Jaap
Reference12 articles.
1. International conference on harmonisation; Guidance on E14 - The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs;Food and Drug Administration;Fed Regist,2005
2. Risks and benefits of phase 1 oncology trials, revisited;Kurzrock;N Engl J Med,2005
3. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility;Telli;J Clin Oncol,2007
4. Paclitaxel and cardiotoxicity;Perez;J Clin Oncol,1998
5. Drug-induced QTc interval prolongation: A proposal toward an efficient and safe anticancer drug development;Curigliano;Eur J Cancer,2008
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献